MoneyWorks4Me

Cadila Healthcare informs about press release

17 Apr 2019 Evaluate

Cadila Healthcare has informed about submission of a press release titled ‘Zydus Announces Phase 3 Trial of Desidustat in Non-Dialysis Dependent Chronic Kidney Disease (CKD) Patients with Anemia’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..